glp-1 supply news today 2025 Novo cuts prices 70%, but semaglutide revenue could grow in 2026 GLP-1 Pipeline Update: November 2025

They have also become popular tools for weight loss and weight management

Your plan may also send an email out during this time to notify you about any changes

DOI: 10.1001/jama.294.19.2437 21

Most people who take a GLP-1 for some time lose up to 20% of their body weightremarkable results indeed

Single molecule fusions of GLP-1 to the peptide hormones gastrin, amylin, and cholecystokinin have been reported, as have fusions of GLP-1 to larger proteins such as FGF21, and to inhibiting antibodies against PCSK9

More recently, the SELECT trial investigated whether semaglutide could reduce cardiovascular risk in individuals with overweight or obesity and preexisting CVD, but not T2DM